All New Diabetics In Scania - ANDIS
type: Dataset
description: ANDIS is a combined research and quality assurance project with the long term aim of introducing precision medicine in diabetes. In connection with a visit to your doctor or diabetes nurse personal identification number, name, address, date of diagnosis, initial and current diabetes treatment, time of start of diabetes treatment, weight and height, possible diabetes during pregnancy, information on the prevalence of diabetes in the family as well as information about the country of birth of the study person and his/her parents was registered. Upon registration, blood samples for determination of GAD antibodies and C-peptide as well as for DNA analysis are taken. The DNA sample is used to classify the disease into subtypes, and to investigate hereditary causes of diabetes, diabetic complications and other medical conditions associated with diabetes. One blood sample is stored for possible future analysis. If the study person previously have given consent for registration of his or her data in the National Diabetes Register (NDR) the study person is asked whether this information can be linked to the ANDIS database on an annual basis. The ANDIS registry is also linked with the Region Skåne Care Database and the register for prescribed drugs to add information about the use of medications and diabetic complications. Ongoing study, currently> 11,000 patients (January 2015). Purpose: To register all new cases of diabetes in Scania and improve diagnosis and treatment strategies. The cohort cover the full spectrum of diabetes in Region Skåne. It has unique representation since a majority of all health care providers, hospitals and clinics participate.
conditions of access: https://publications.europa.eu/resource/authority/access-right/NON_PUBLIC
conditions of access: info:eu-repo/semantics/restrictedAccess
creative work status: completed
  type: DefinedTerm
  in defined term set: http://publications.europa.eu/resource/authority/dataset-status
  term code: COMPLETED
creator: Leif Groop
  type: Person
  affiliation: Lunds universitet
  family name: Groop
  given name: Leif
date modified: 2025-06-23
date published: 2013-09-06
keywords: HEALTH
keywords: Medical and Health Sciences
  type: DefinedTerm
  term code: 3
keywords: Clinical Medicine
  type: DefinedTerm
  term code: 302
keywords: Endocrinology and Diabetes
  type: DefinedTerm
  term code: 30205
keywords: Blood Specimen Collection
keywords: Diabetes Mellitus
keywords: DNA
keywords: Classification
keywords: Drug Utilization
keywords: Disease Progression
keywords: Diabetes Mellitus, Type 2
keywords: C-Peptide
keywords: Diabetes Mellitus, Type 1
keywords: Prognosis
keywords: GAD- antibodies
keywords: national diabetes registry
keywords: complications
keywords: Scania
keywords: EpiHealth_Skåne
keywords: EpiHealth
publisher: Lunds universitet
temporal coverage: 2008
distribution: documentation/Datainspektionen -1.pdf
  type: DataDownload
  additional type: documentation
  conditions of access: http://publications.europa.eu/resource/authority/access-right/PUBLIC
  conditions of access: info:eu-repo/semantics/openAccess
  content size: 826504
  encoding format: application/pdf
distribution: documentation/Etiskt tillstånd ANDIS.pdf
  type: DataDownload
  additional type: documentation
  conditions of access: http://publications.europa.eu/resource/authority/access-right/PUBLIC
  conditions of access: info:eu-repo/semantics/openAccess
  content size: 714432
  encoding format: application/pdf
distribution: documentation/Patient info ANDIS 2011_sv.pdf
  type: DataDownload
  additional type: documentation
  conditions of access: http://publications.europa.eu/resource/authority/access-right/PUBLIC
  conditions of access: info:eu-repo/semantics/openAccess
  content size: 31255
  encoding format: application/pdf
distribution: documentation/Patient_föraldrainformation_om_genetiska_analyser_070205.pdf
  type: DataDownload
  additional type: documentation
  conditions of access: http://publications.europa.eu/resource/authority/access-right/PUBLIC
  conditions of access: info:eu-repo/semantics/openAccess
  content size: 12466
  encoding format: application/pdf
version: 1

Lunds universitet
type: Organization
department: Institutionen för kliniska vetenskaper, avdelningen för diabetes och endokrinologi
name: Lund University

HEALTH
type: DefinedTerm
term code: Health

Blood Specimen Collection
type: DefinedTerm
description: The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc.
term code: D001800

Diabetes Mellitus
type: DefinedTerm
description: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
term code: D003920

DNA
type: DefinedTerm
description: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
term code: D004247

Classification
type: DefinedTerm
description: The systematic arrangement of entities in any field into categories classes based on common characteristics such as properties, morphology, subject matter, etc.
term code: D002965

Drug Utilization
type: DefinedTerm
description: The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.
term code: D004363

Disease Progression
type: DefinedTerm
description: The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
term code: D018450

Diabetes Mellitus, Type 2
type: DefinedTerm
description: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
term code: D003924

C-Peptide
type: DefinedTerm
description: The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
term code: D002096

Diabetes Mellitus, Type 1
type: DefinedTerm
description: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
term code: D003922

Prognosis
type: DefinedTerm
description: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
term code: D011379